Columnist: Rebecca Fazio-Goldstein
Rebecca Goldstein earned her PhD in Cell Biology in 2007 from the University of Alabama at Birmingham, where her research characterized immunotherapy and targeted molecular therapies. She then transitioned to medical communications, serving first as a freelance science writer and then as a staff medical writer for KnowledgePoint360 Group. During her 6-year tenure with the company, she advanced twice, to Scientific Director, and also became a Certified Medical Publication Professional (CMPP). Currently, as Vice President of Medical Strategy for Alligent, Dr. Goldstein directs strategy
and execution of medical affairs activities for pharmaceutical clients.